Regorafenib

Regorafenib (brand name Stivarga) is an oral medication used primarily to treat certain types of cancer, including colorectal cancer, gastrointestinal stromal tumors (GISTs), liver cancer (HCC), and soft tissue sarcoma. It belongs to a class of drugs called multikinase inhibitors, meaning it works by inhibiting multiple enzymes that promote the growth and spread of cancer cells.